手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| Cost-Effectiveness Analysis in HTA× | 臨床監査× | |
|---|---|---|
| 分野 | 医療経営学 | 医療経営学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1996 | 1989 |
| 提唱者≠ | Diane Meade Drummond, Michael Gold | UK National Health Service and healthcare quality movements |
| 種類≠ | Economic evaluation methodology | Systematic quality review methodology |
| 原典≠ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press. ISBN: 9780195108231 | Institute of Medicine. (2001). Crossing the Quality Chasm: A New Health System for the 21st Century. National Academies Press. DOI ↗ |
| 別名 | CEA, Cost-Effectiveness Analysis Healthcare | Medical Audit, Healthcare Quality Audit |
| 関連 | 5 | 5 |
| 概要≠ | Cost-Effectiveness Analysis (CEA) is an economic evaluation method that compares the cost and health benefits of alternative treatments to determine whether an intervention provides good value for money. Within Health Technology Assessment, CEA is the primary tool for recommending reimbursement and coverage decisions. | Clinical audit is a systematic, cyclical process that measures the quality of clinical care against evidence-based standards and benchmarks, identifies gaps, and implements improvements to bring practice into alignment with current best evidence. Originating in the UK NHS, clinical audit is now a fundamental quality assurance tool in healthcare organizations worldwide. |
| ScholarGateデータセット ↗ |
|
|